Cognitive Dysfunction Among Cancer Survivors
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Cognitive dysfunction among cancer survivors, commonly referred to as "chemobrain," has gained increased attention in the last decade. Cognitive dysfunction is now well recognized among patients with non-central nervous system cancers. It may be a consequence of the cancer, its treatment, or both. Other common problems among cancer survivors, such as insomnia, pain, depression, and fatigue, may play a role in cognitive performance. Three options to assess cognitive function at present include neuropsychologic testing, functional neuroimaging studies, and subjective evaluations, although no "gold standard" currently exists. Treatment options for survivors with cognitive problems are limited because research in this arena is in its infancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Fitness Effects on the Cognitive Function of Older Adults: A Meta-Analytic Study
Colcombe, S., & Kramer, A. F. (2003) · Psychological Science · doi:10.1111/1467-9280.t01-1-01430 · Cited by 3,782
Thompson, P. D., Buchner, D., Piña, I. L., Balady, G. J., Williams, M. A., Marcus, B. H., Berra, K., Blair, S. N., Costa, F., Franklin, B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000075572.40158.77 · Cited by 2,132
Cardiovascular fitness, cortical plasticity, and aging
Colcombe, S. J., Kramer, A. F., Erickson, K. I., Scalf, P., McAuley, E., Cohen, N. J., Webb, A., Jerome, G. J., Marquez, D. X., & Elavsky, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400266101 · Cited by 1,648 · cited 2×
“In another study, Colcombe et al.(87) evaluated the effects of a 6-mo aerobic exercise intervention vs.”
BackgroundExercise and brain neurotrophins
Neeper, S. A., Góauctemez-Pinilla, F., Choi, J., & Cotman, C. (1995) · Nature · doi:10.1038/373109a0 · Cited by 1,066 · cited 1×
“Other researchers have found that increased aerobic fitness increases brain-derived neurotrophin factor gene expression in rats.(84) Brain-derived neurotrophin factor has been popularly referred to as the ‘‘fertilizer’’ of the neuron and is believed to improve the function and growth of neurons.”
BackgroundCancer-related fatigue: the scale of the problem
Hofman, M., Ryan, J. L., Figueroa-Moseley, C. D., Jean-Pierre, P., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-4 · Cited by 895 · cited 1×
“Cancer-related fatigue is one of the most common and distressing symptoms associated with cancer and its treatment.(40,41) Although clinical intuition would suggest that the symptoms of cancer-related fatigue (i.”
BackgroundCytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Insomnia in the Context of Cancer: A Review of a Neglected Problem
Savard, J., & Morin, C. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.895 · Cited by 861
A meta-regression to examine the relationship between aerobic fitness and cognitive performance
Etnier, J. L., Nowell, P. M., Landers, D. M., & Sibley, B. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.01.002 · Cited by 749
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Irwin, M. R., Cole, J. C., & Nicassio, P. M. (2006) · Health Psychology · doi:10.1037/0278-6133.25.1.3 · Cited by 537
Exercise and the Treatment of Clinical Depression in Adults: Recent Findings and Future Directions
Brosse, A. L., Sheets, E. S., Lett, H. S., & Blumenthal, J. A. (2002) · Sports Medicine · doi:10.2165/00007256-200232120-00001 · Cited by 505
Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines
Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., & Fleshner, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.090 · Cited by 424
Monk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179 · cited 1×
“For example, etanercept (which is a tumor necrosis factor inhibitor) has been shown to reduce cancer-related fatigue.(67) Whether these agents can improve cognitive dysfunction in patients undergoing cancer treatment is unknown.”
BackgroundThe Blood–Brain Barrier in Psychoneuroimmunology
Banks, W. A. (2006) · Neurologic Clinics · doi:10.1016/j.ncl.2006.03.009 · Cited by 83
Cited by
From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
Bajic, J. E., Johnston, I. N., Howarth, G. S., & Hutchinson, M. R. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00104 · Cited by 100
Baumann, F. T., Bieck, O., Oberste, M., Kuhn, R., Schmitt, J., Wentrock, S., Zopf, E., Bloch, W., Schüle, K., & Reuss-Borst, M. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-016-3490-x · Cited by 60
“Despite continuously improving treatment options, the medical treatment for breast cancer has a lot of side effects on the physical [3, 4], mental [5, 6], and * Freerk T.”
BackgroundAssociation of functional dorsal attention network alterations with breast cancer and chemotherapy
Shen, C.-Y., Chen, V. C.-H., Yeh, D.-C., Huang, S.-L., Zhang, X.-R., Chai, J.-W., Huang, Y.-H., Chou, M.-C., & Weng, J.-C. (2019) · Scientific Reports · doi:10.1038/s41598-018-36380-6 · Cited by 34
Metadata
- Authors
- Asher, A.
- Venue
- American Journal of Physical Medicine & Rehabilitation
- Published
- 2011-05
- Volume
- 90
- Issue
- 5
- Pages
- S16-S26
- ISSN
- 0894-9115 (ISSN-L)
- OpenAlex
- W2036090033
- Cited by
- 89
- References
- 16
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.